RUA Life Sciences has reported final results for the 12-months to March 2023, with group revenues of £2.2m, up 34% YoY and a loss before tax improved marginally to £2.3m from £2.4m. Cash at the end of the period was £1.5m. We believe the company has delivered strong operational progress across all four of its businesses, with its revenue generating units showing strong revenue growth and improved profitability, while its ‘development' units have both made progress towards future commercialisatio ....
26 Jul 2023
Cenkos: RUA Life Sciences Plc -- Final results
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Cenkos: RUA Life Sciences Plc -- Final results
RUA Life Sciences Plc (RUA:LON) | 10.5 0 0.0% | Mkt Cap: 6.52m
- Published:
26 Jul 2023 -
Author:
Chris Donnellan -
Pages:
7
RUA Life Sciences has reported final results for the 12-months to March 2023, with group revenues of £2.2m, up 34% YoY and a loss before tax improved marginally to £2.3m from £2.4m. Cash at the end of the period was £1.5m. We believe the company has delivered strong operational progress across all four of its businesses, with its revenue generating units showing strong revenue growth and improved profitability, while its ‘development' units have both made progress towards future commercialisatio ....